Nuveen Asset Management, LLC 89bio, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 286,492 shares of ETNB stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

286,492

Previous 289,912 1.18%

Holding current value

$2.82 Million

Previous $2.15 Million 2.42%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.03 - $10.05 $24,042 - $34,371	-3,420 Reduced 1.18%	286,492 $2.2 Million
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $50,128 - $65,794	6,811 Added 2.41%	289,912 $2.15 Million
Q2 2024 Aug 09, 2024	SELL	$7.31 - $10.9 $1.96 Million - $2.92 Million	-267,493 Reduced 48.58%	283,101 $2.27 Million
Q1 2024 May 13, 2024	BUY	$8.13 - $13.77 $2.51 Million - $4.24 Million	308,205 Added 127.15%	550,594 $6.41 Million
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $1.04 Million - $2.49 Million	-155,413 Reduced 39.07%	242,389 $2.71 Million
Q3 2023 Nov 14, 2023	BUY	$15.06 - $19.41 $328,232 - $423,040	21,795 Added 5.8%	397,802 $6.14 Million
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $5.32 Million - $8.28 Million	376,007 New	376,007 $7.13 Million
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $81,313 - $156,402	-38,906 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $14.99 $59,457 - $258,337	-17,234 Reduced 30.7%	38,906 $149,000
Q4 2021 Feb 14, 2022	SELL	$11.15 - $19.66 $46,294 - $81,628	-4,152 Reduced 6.89%	56,140 $664,000
Q3 2021 Nov 12, 2021	BUY	$14.91 - $21.31 $84,658 - $120,998	5,678 Added 10.4%	60,292 $1.28 Million
Q2 2021 Aug 16, 2021	SELL	$17.42 - $28.0 $179,391 - $288,344	-10,298 Reduced 15.86%	54,614 $1.02 Million
Q1 2021 May 17, 2021	SELL	$20.22 - $26.73 $151,164 - $199,833	-7,476 Reduced 10.33%	64,912 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $132,289 - $160,392	5,712 Added 8.57%	72,388 $1.76 Million
Q3 2020 Nov 16, 2020	BUY	$24.34 - $38.82 $1.62 Million - $2.59 Million	66,676 New	66,676 $1.71 Million
Q2 2020 Aug 14, 2020	SELL	$19.93 - $31.2 $869,545 - $1.36 Million	-43,630 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$16.4 - $41.77 $715,531 - $1.82 Million	43,630 New	43,630 $1.1 Million

Others Institutions Holding ETNB

# of Institutions

208

Shares Held

158M

Call Options Held

366K

Put Options Held

944K

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $457M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC 89bio, Inc. Transaction History